The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.


Updates from The Motley Fool

Latest updates on SPDR S&P Pharmaceuticals from Fool.com.
These 3 ETFs Jumped in November

Even as the stock market put in a tepid performance, these ETFs managed to produce sizable gains....



Stock Performance

View Interactive XPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about SPDR S&P Pharmaceuticals.
Current Price: $44.34
Prev Close: $44.24
Open: $44.32
Bid: $44.33
Ask: $44.36
Day's Range: $44.28 - $44.44
52wk Range: $36.58 - $47.82
Volume: 54,457
Avg Vol 75,217
Market Cap: $470M
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.34 (0.6%)

Company Rating

What our community thinks about SPDR S&P Pharmaceuticals.
CAPS Rating 2 out of 5
 
29 Outperform
7 Underperform
CAPS All Stars
 
5 Outperform
2 Underperform

How do you think SPDR S&P Pharmaceuticals will perform against the market?



You pick for SPDR S&P Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for SPDR S&P Pharmaceuticals.

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.

  • Exchange: NYSEMKT
  • Sector: Sector Equity
  • Industry: Health/Biotechnology Funds